Term
|
Definition
| trying to prevent something from happeniong (MI) from ever happening |
|
|
Term
| secondary prevention iss? |
|
Definition
| trying to prevent something from reoccuring |
|
|
Term
| subclinical atheroscelrosis can be: -3 |
|
Definition
| stable angina, asymptoamtic |
|
|
Term
| clinical atherscleorsis event: -3 |
|
Definition
ACS/myocardial infarction
CVA |
|
|
Term
| most common antithrombotic |
|
Definition
|
|
Term
| what type of preventin does the global risk screening classify as? |
|
Definition
|
|
Term
| primary prevention of CAD/CHD wants to control risk factors of? |
|
Definition
|
|
Term
| is secodnary or primary prevention use more aggresive therapy? |
|
Definition
|
|
Term
comprehensive risk screeing should be done at what age for men? woemn?
repeat when? |
|
Definition
|
|
Term
| why do you do comprehensive risk screening |
|
Definition
| identify and manage risk factors |
|
|
Term
| for the comprehensive risk screening-what do you NOT do |
|
Definition
| framingham score-bc everyone will have a low score |
|
|
Term
| when do you do calculate a risk score? |
|
Definition
|
|
Term
| steps for doing a global risk assessment |
|
Definition
1) calc score
2) explain the score to pateint
3) explain how modifable factrs can help reduce risk |
|
|
Term
| when do you do a global risk assessment for men? for women? |
|
Definition
|
|
Term
| systemically triaging for CV risk model- |
|
Definition
|
|
Term
| what are the CV risks you are triaging for |
|
Definition
hypertension
diabetes
dyslipidemia
lifestyle
antithrombotic |
|
|
Term
| why do you want glycemic control? |
|
Definition
prevent progression of microvascular complicaiton
NOT for reducing cv events |
|
|
Term
| want to reduce weight to: |
|
Definition
|
|
Term
| for exercise, what may need to be reccomedned if have history of CAD, like MI? |
|
Definition
|
|
Term
alchol intake for men:
for women? |
|
Definition
|
|
Term
| artheroemolic events is where what ruptures? this has caused- 2? |
|
Definition
|
|
Term
artheroemolbic events concentrate on what agents?
what is the most common? |
|
Definition
|
|
Term
| cardioembolic evetn is where abnormal _ (3 things) puts you at risk of clotting |
|
Definition
| blood flow/inflammation/endotheial |
|
|
Term
cardioembolic therapy concentrate on what agents?
what is the most common? |
|
Definition
|
|
Term
what process is CAD classified as?
arthero or cario |
|
Definition
|
|
Term
| primary prevent for artheremobilic events |
|
Definition
|
|
Term
| for primary prevention of atheroembolic- what meds do you not substitue for aspirin? |
|
Definition
|
|
Term
| when do you avoid aspirin primiary prevention? |
|
Definition
| peptic ulcer risk- frequent NSAIDS, GI pain/ulcer |
|
|
Term
men hvae more _ events
women have more _ |
|
Definition
|
|
Term
for secondary prevention of Silent CAD, stable angina, and PVD?
what substutites can be made? |
|
Definition
aspirin 75-162;
clopidogrel 75 |
|
|
Term
| for secodnary prevention of unstable angina/STEMI/NSTEMI |
|
Definition
| aspirin 75-162 + P2Y12 inhibitor |
|
|
Term
| how long do you keep a P2Y12 inhibitor on for when added to aspirirn? |
|
Definition
| 12 months after intital event |
|
|
Term
| for secondary prevention use of aspirin, what do you do if have risk of GI ulcer? |
|
Definition
| fix the ulcer porbelm and cont aspirin |
|
|
Term
| artherembolic stokres are not due to- 2 |
|
Definition
atrial fibrilation
valvular disease |
|
|
Term
| what is the only P2Y12 agent used for artherembolic stroke? |
|
Definition
|
|
Term
| secondary prevention for artherembolic stroke start this therapy: -3 |
|
Definition
aspirin- 50-325
clopidogrel 75
Aggrenox- 20/200 BID |
|
|
Term
| what is the major side affect of aggrenox? |
|
Definition
|
|
Term
| do you combine ASA with clopidgrel for prevention of recurrent arthemb stroke? |
|
Definition
| no! you can for unstable agina, but not stroke! |
|
|
Term
| which type of event has high risk for stroek regarldess of secodnary/primary prevneiton? |
|
Definition
|
|
Term
| For Afib- what do you need to calcualte for prevention? |
|
Definition
|
|
Term
|
Definition
no anticoag
reccomend anticoag- warfarin, dabigitran, etc
strongly reccomedn anticoag |
|
|
Term
even if the CHADS2 score is 1 or greater, when do you not use anticoag?
what do you use instead? |
|
Definition
if hgih risk of bleeding
ASA +/- Plavix |
|
|
Term
if have heart valve replacement with MECHANICAL prothesis- what med to use for cardioembo stroke prevention?
can you add on another agent? |
|
Definition
warfarin
yes- aspirin 81 mg if still ahve CVA/TIA |
|
|
Term
| when is a person;s CHADS2 automatically 2 and need anticoag? |
|
Definition
|
|
Term
| what is the only contraindication for plavix and aggrenox? |
|
Definition
|
|
Term
| what are the contrindicaitons for aspriin- 3 |
|
Definition
hypersens.
anaphylaxis
asthma |
|
|
Term
| for all antiplatelet agents- what is a precautoin- 2 |
|
Definition
|
|
Term
| why are the other anticoags not used fro prevneiton of cardio strreokf rom mechanical valve? |
|
Definition
|
|
Term
what is the dose of Dabigatran
Rivaroxaban
Apixaban |
|
Definition
75-150 BID
15-20
2.5-5 BID |
|
|
